• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞和血浆促凝活性对纤维蛋白网络的影响。

Influence of cellular and plasma procoagulant activity on the fibrin network.

机构信息

Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, NC 27599-7525, USA.

出版信息

Thromb Res. 2010 Apr;125 Suppl 1:S35-7. doi: 10.1016/j.thromres.2010.01.033. Epub 2010 Feb 16.

DOI:10.1016/j.thromres.2010.01.033
PMID:20163831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2839015/
Abstract

At the nexus of cellular and plasma procoagulant activities lies fibrin, which is necessary to provide a clot's structural support. Abnormalities in fibrin network formation or function can result in either bleeding or thrombotic complications. Understanding relationships between procoagulant activity and normal fibrin formation, as well as pathophysiologic mechanisms leading to abnormal fibrin deposition, is essential for the continued development of hemostatic and antithrombotic therapies.

摘要

在细胞和血浆促凝活性的交汇点是纤维蛋白,它是提供血栓结构支撑所必需的。纤维蛋白网络形成或功能的异常可导致出血或血栓并发症。了解促凝活性与正常纤维蛋白形成之间的关系,以及导致异常纤维蛋白沉积的病理生理机制,对于继续开发止血和抗血栓治疗至关重要。

相似文献

1
Influence of cellular and plasma procoagulant activity on the fibrin network.细胞和血浆促凝活性对纤维蛋白网络的影响。
Thromb Res. 2010 Apr;125 Suppl 1:S35-7. doi: 10.1016/j.thromres.2010.01.033. Epub 2010 Feb 16.
2
Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.肝硬化患者纤维蛋白凝块结构中的促凝变化与纤维蛋白原的氧化修饰有关。
J Thromb Haemost. 2016 May;14(5):1054-66. doi: 10.1111/jth.13278. Epub 2016 Mar 7.
3
Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis.凝血酶-纤维蛋白(原)相互作用、宿主防御与血栓风险。
Int J Mol Sci. 2021 Mar 4;22(5):2590. doi: 10.3390/ijms22052590.
4
Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.在人血液流过胶原蛋白/组织因子伤口的过程中,纤维蛋白、γ'-纤维蛋白原和跨凝块压力梯度控制着止血凝块的生长。
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):645-54. doi: 10.1161/ATVBAHA.114.305054. Epub 2015 Jan 22.
5
The role of procoagulants and anticoagulants in the development of venous thromboembolism.促凝血剂和抗凝血剂在静脉血栓栓塞形成中的作用。
Thromb Res. 2009;123 Suppl 4:S41-5. doi: 10.1016/S0049-3848(09)70142-2.
6
Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.动力学模型有助于分析纤维蛋白生成及其受凝血因子的调节:对止血增强疗法的启示。
Mol Biosyst. 2014 Jul 29;10(9):2347-57. doi: 10.1039/c4mb00263f.
7
Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.血流和压力差决定了凝血酶、纤维蛋白和血管性血友病因子的存在位置。
Thromb Res. 2016 May;141 Suppl 2:S22-4. doi: 10.1016/S0049-3848(16)30357-7.
8
Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.中性粒细胞组织蛋白酶G通过激活黏附纤维蛋白原的血小板,在流动条件下促进凝血酶原酶和纤维蛋白的形成。
J Biol Chem. 2003 Mar 14;278(11):9458-63. doi: 10.1074/jbc.M211956200. Epub 2003 Jan 10.
9
Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.建立血栓的瞬态质量平衡:从组织因子到凝血酶到静脉血流下的纤维蛋白。
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1528-1536. doi: 10.1161/ATVBAHA.118.310906. Epub 2018 May 3.
10
Plasma and cellular contributions to fibrin network formation, structure and stability.血浆和细胞对纤维蛋白网络形成、结构和稳定性的贡献。
Haemophilia. 2010 May;16 Suppl 3:7-12. doi: 10.1111/j.1365-2516.2010.02253.x.

引用本文的文献

1
Flow affects the structural and mechanical properties of the fibrin network in plasma clots.血流会影响血浆凝块中纤维蛋白网络的结构和力学性能。
J Mater Sci Mater Med. 2024 Jan 29;35(1):8. doi: 10.1007/s10856-024-06775-1.
2
Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasis.表达不可聚合纤维蛋白原的小鼠具有降低的动静脉血栓形成而保留止血功能。
Blood. 2024 Jan 11;143(2):105-117. doi: 10.1182/blood.2023020805.
3
Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions.全面综述 COVID-19 相关呼吸衰竭:聚焦细胞间相互作用。
Cell Mol Biol Lett. 2022 Jul 30;27(1):63. doi: 10.1186/s11658-022-00363-3.
4
Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.癌症患者静脉血栓栓塞、动脉血栓形成和死亡风险的血浆凝块形成和溶解的体外特性。
Transl Res. 2020 Jan;215:41-56. doi: 10.1016/j.trsl.2019.08.009. Epub 2019 Aug 29.
5
MetAmyl: a METa-predictor for AMYLoid proteins.MetAmyl:淀粉样蛋白的 METa 预测器。
PLoS One. 2013 Nov 19;8(11):e79722. doi: 10.1371/journal.pone.0079722. eCollection 2013.
6
Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.Aβ 通过改变纤维蛋白结构和减弱纤溶酶原与纤维蛋白的结合来延迟纤维蛋白凝块的溶解。
Blood. 2012 Apr 5;119(14):3342-51. doi: 10.1182/blood-2011-11-389668. Epub 2012 Jan 11.
7
Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis.血流对纤维蛋白网络结构有深远影响:对止血过程中纤维蛋白形成和血凝块稳定性的意义。
Thromb Haemost. 2010 Dec;104(6):1281-4. doi: 10.1160/TH10-07-0442. Epub 2010 Sep 30.

本文引用的文献

1
Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis.吸烟对血浆纤维蛋白凝块通透性及溶解易感性的影响。
Thromb Haemost. 2009 Dec;102(6):1289-91. doi: 10.1160/TH09-03-0187.
2
Altered plasma fibrin clot properties are associated with in-stent thrombosis.血浆纤维蛋白凝块特性的改变与支架内血栓形成有关。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):276-82. doi: 10.1161/ATVBAHA.109.194936. Epub 2009 Nov 12.
3
Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.烟雾暴露对血栓动力学和纤维蛋白结构的影响:一项离体研究。
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):75-9. doi: 10.1161/ATVBAHA.109.195024. Epub 2009 Oct 8.
4
Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.血管外细胞和血管内细胞对纤维蛋白网络形成、结构和稳定性的贡献。
Blood. 2009 Nov 26;114(23):4886-96. doi: 10.1182/blood-2009-06-228940. Epub 2009 Oct 1.
5
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.特发性静脉血栓栓塞症患者及其亲属的纤维蛋白凝块结构/功能改变。
Blood. 2009 Nov 5;114(19):4272-8. doi: 10.1182/blood-2009-05-222380. Epub 2009 Aug 18.
6
High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压患者中异常纤维蛋白原血症的高患病率。
Blood. 2009 Aug 27;114(9):1929-36. doi: 10.1182/blood-2009-03-208264. Epub 2009 May 6.
7
Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.细胞促凝活性决定了凝块结构和稳定性,这是细胞表面距离的函数。
Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2247-54. doi: 10.1161/ATVBAHA.108.176008. Epub 2008 Oct 30.
8
Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition.组织因子途径抑制剂和血栓调节蛋白联合缺乏会产生增强的高凝状态,并伴有组织特异性纤维蛋白沉积。
J Thromb Haemost. 2008 Jan;6(1):111-7. doi: 10.1111/j.1538-7836.2007.02817.x. Epub 2007 Oct 25.
9
Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress.急性冠状动脉综合征患者血栓通透性降低及对溶解的易感性:炎症和氧化应激的影响
Atherosclerosis. 2008 Feb;196(2):551-7. doi: 10.1016/j.atherosclerosis.2007.05.028. Epub 2007 Jul 20.
10
Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.纤维蛋白结构改变与纤维蛋白溶解功能减退及冠状动脉粥样硬化血栓形成过早有关。
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2567-73. doi: 10.1161/01.ATV.0000241589.52950.4c. Epub 2006 Aug 17.